http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011150894-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7012 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 2010-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011150894-A |
| titleOfInvention | TREATMENT CARBOHYDRATES FOR TREATMENT OF RESPIRATORY DISEASES |
| abstract | 1. A method of activating the restoration of viability of an affected respiratory cell, comprising the step of introducing into the cell at least one pharmaceutically acceptable compound capable of accelerating the biosynthesis of sialylated glycoconjugates. The method according to claim 1, where at least one pharmaceutically acceptable compound is selected from the group consisting of compounds of formula (1) and compounds of formula (2), where the compound of formula (1) has the formula: in which R, R, R are the same or different and each independently selected from the group consisting of H, CH, (CH) CH (n = 1-20), CHPh, COCRRR and CO-active esters; R, R, R are the same or different and each independently the other is selected from the group consisting of H, CH, (CH) CH (n = 1-20), CH, CHPh, and CHCH (OCHCH) CH (m = 1-200); R is the same or different from R, R, R selected from the group consisting of H, CH, (CH) CH (n = 1-20), CHPh, COCRRR, CO-active esters and R, R are the same or different and each independently selected from the group consisting of H or a pharmaceutically suitable inorganic or organic salt and a pharmaceutically suitable ester; one of A and B is H, provided that: in cases where B is H, then A is selected from the group consisting of (NHCOCH, NH, OH, NH · HX), or in cases where A is H, then B is selected from the group consisting of NHCOCH, NH, and NH · HX, wherein HX is a pharmaceutically acceptable inorganic or organic acid; wherein the compound of formula (2) has the formula wherein R is selected from the group consisting of H, CH, (CH) CH (n = 1-20), CHPh, COCHPh, CO- active ester and COCRRR; where R, R, R are the same or different and each independent |
| priorityDate | 2009-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 210.